Hidradenitis suppurativa: bacteriological study in surgical treatment.

Marcin Gierek, Gabriela Ochała-Gierek, Diana Kitala, Wojciech Łabuś, Beata Bergler-Czop
Author Information
  1. Marcin Gierek: Dr Sakiel's Centre for Burn Treatment, Siemianowice Śląskie, Poland.
  2. Gabriela Ochała-Gierek: Department of Dermatology and Venereology, Sosnowiec City Hospital, Sosnowiec, Poland.
  3. Diana Kitala: Dr Sakiel's Centre for Burn Treatment, Siemianowice Śląskie, Poland.
  4. Wojciech Łabuś: Dr Sakiel's Centre for Burn Treatment, Siemianowice Śląskie, Poland.
  5. Beata Bergler-Czop: Department of Dermatology, Medical University of Silesia, Katowice, Poland.

Abstract

Introduction: Hidradenitis suppurativa (HS) is an inflammatory chronic disease of the hair follicles that presents with different lesions in the apocrine gland-bearing areas of the human body. There are many possible factors for HS. Acne inversa is not primarily considered to be an infectious disease. A variety of Gram-positive and Gram-negative bacteria have been found from the lesions sporadically.
Aim: To assess the bacteriological profile of HS before surgical treatment.
Material and methods: We collected specimens for aerobic microbiological testing from 18 patients before surgical treatment in our hospital. The specimens were obtained from abscesses, directly from skin fistulas, on day 1 of hospitalisation.
Results: The most common bacteria in HS lesions were Staphylococcus aureus and Proteus mirabilis. In 4 patients we found multi-drug-resistant bacteria (MLSB, MRSA and A. baumannii).
Conclusions: Long-term antibiotic treatment can cause multi-drug resistance in strains collected in HS lesions.

Keywords

References

  1. Dermatoendocrinol. 2010 Jan;2(1):9-16 [PMID: 21547142]
  2. Exp Dermatol. 2012 Oct;21(10):735-9 [PMID: 22882284]
  3. J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44 [PMID: 25640693]
  4. Emerg Infect Dis. 2014 Dec;20(12):1990-8 [PMID: 25418454]
  5. Br J Dermatol. 2012 May;166(5):1023-34 [PMID: 22136668]
  6. Br J Dermatol. 2018 Jan;178(1):e15-e16 [PMID: 28626900]
  7. J Am Acad Dermatol. 1998 Dec;39(6):971-4 [PMID: 9843011]
  8. Dermatology. 2006;213(4):305-12 [PMID: 17135736]
  9. J Invest Dermatol. 2012 Oct;132(10):2459-2461 [PMID: 22622421]
  10. Br J Dermatol. 2011 Aug;165(2):415-8 [PMID: 21495993]
  11. Nat Rev Dis Primers. 2020 Mar 12;6(1):18 [PMID: 32165620]
  12. J Med Microbiol. 1999 Jan;48(1):103-105 [PMID: 9920133]
  13. Dermatology. 1996;193(3):203-6 [PMID: 8944341]
  14. Acta Derm Venereol. 2014 Nov;94(6):699-702 [PMID: 24604152]
  15. Br J Dermatol. 2018 Mar;178(3):603-613 [PMID: 27905098]
  16. Front Cell Infect Microbiol. 2017 Mar 13;7:55 [PMID: 28348979]
  17. Br J Dermatol. 1999 Jan;140(1):90-5 [PMID: 10215774]
  18. J Invest Dermatol. 2011 Jul;131(7):1568-70 [PMID: 21412258]
  19. Curr Opin Infect Dis. 2011 Apr;24(2):118-23 [PMID: 21192260]
  20. Clin Microbiol Rev. 1999 Jan;12(1):80-96 [PMID: 9880475]
  21. J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1800-1808 [PMID: 28516469]
  22. J Invest Dermatol. 2011 Jul;131(7):1570-2 [PMID: 21430701]
  23. Dermatology. 2009;219(1):22-4 [PMID: 19365106]
  24. APMIS. 2014 Sep;122(9):804-9 [PMID: 24475943]
  25. J Med Genet. 1985 Oct;22(5):367-73 [PMID: 2934550]
  26. Antibiotics (Basel). 2021 Nov 17;10(11): [PMID: 34827344]
  27. Skin Appendage Disord. 2015 Sep;1(2):55-9 [PMID: 27170935]
  28. Int J Antimicrob Agents. 2000 Nov;16 Suppl 1:S3-10 [PMID: 11137402]
  29. J Am Acad Dermatol. 2017 Feb;76(2):309-313.e2 [PMID: 27742173]
  30. Dermatol Clin. 2016 Jan;34(1):81-9 [PMID: 26617361]
  31. Int J Med Microbiol. 2013 Aug;303(6-7):324-30 [PMID: 23517691]
  32. Nat Rev Microbiol. 2011 Apr;9(4):244-53 [PMID: 21407241]
  33. Br J Dermatol. 2012 Apr;166(4):879-83 [PMID: 22098253]
  34. Science. 2010 Nov 19;330(6007):1065 [PMID: 20929727]
  35. Skin Pharmacol Physiol. 2016;29(3):161-7 [PMID: 27351708]
  36. Arch Immunol Ther Exp (Warsz). 2019 Feb;67(1):1-18 [PMID: 30302512]
  37. Br J Dermatol. 2016 Mar;174(3):514-21 [PMID: 26436522]
  38. Medicine (Baltimore). 2014 Dec;93(27):e187 [PMID: 25501066]

Word Cloud

Created with Highcharts 10.0.0HSlesionstreatmentbacteriasurgicalHidradenitissuppurativadiseasefoundbacteriologicalcollectedspecimenspatientsMRSAIntroduction:inflammatorychronichairfolliclespresentsdifferentapocrinegland-bearingareashumanbodymanypossiblefactorsAcneinversaprimarilyconsideredinfectiousvarietyGram-positiveGram-negativesporadicallyAim:assessprofileMaterialmethods:aerobicmicrobiologicaltesting18hospitalobtainedabscessesdirectlyskinfistulasday1hospitalisationResults:commonStaphylococcusaureusProteusmirabilis4multi-drug-resistantMLSBbaumanniiConclusions:Long-termantibioticcancausemulti-drugresistancestrainssuppurativa:studybacteriologyhidradenitis

Similar Articles

Cited By